Semaglutide versus Tirzepatide - comparison of both drugs in treatment of diabetes type 2 and weight reduction

Autor: Arkadiusz Staroń, Patrycja Karkos, Katarzyna Kuśmierczyk, Bartłomiej Gastoł, Karolina Mikołap, Marta Kras, Marta Jurga
Jazyk: angličtina
Rok vydání: 2024
Předmět:
Zdroj: Quality in Sport, Vol 19 (2024)
Druh dokumentu: article
ISSN: 2450-3118
DOI: 10.12775/QS.2024.19.53518
Popis: In recent years, the popularity of drugs which were firstly introduced as treatment for diabetes type 2 has surged, because of their’s significant effect of managing the body weight especially for patients that suffer for diabetes type 2. Tirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide is a glucagon-like-peptide 1 receptor agonist. The aim of our study is to present reliable and up-to-date knowledge of effects that both drugs provide and their beneficial effects on health.
Databáze: Directory of Open Access Journals